Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.39−0.11 (-0.49%)
Close on Nov 18, 2026Market cap $455.87MP/E –Yield –
Assembly Biosciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Assembly Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$8.80M. For fiscal 2025 it was -$12.12M. The highest annual figure on record is -$3.34M in fiscal 2009.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.12M | – |
| FY2024 | Dec 31, 2024 | -$45.42M | – |
| FY2023 | Dec 31, 2023 | -$64.65M | – |
| FY2022 | Dec 31, 2022 | -$94.11M | – |
| FY2021 | Dec 31, 2021 | -$132.69M | – |
| FY2020 | Dec 31, 2020 | -$64.78M | – |
| FY2019 | Dec 31, 2019 | -$102.71M | – |
| FY2018 | Dec 31, 2018 | -$92.74M | – |
| FY2017 | Dec 31, 2017 | -$52.23M | – |
| FY2016 | Dec 31, 2016 | -$45.28M | – |
| FY2015 | Dec 31, 2015 | -$29.66M | – |
| FY2014 | Dec 31, 2014 | -$23.96M | – |
| FY2013 | Dec 31, 2013 | -$19.60M | – |
| FY2012 | Dec 31, 2012 | -$24.86M | – |
| FY2011 | Dec 31, 2011 | -$34.00M | – |
| FY2010 | Dec 31, 2010 | -$4.77M | – |
| FY2009 | Dec 31, 2009 | -$3.34M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.34M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.37M | – |
| Q4 FY2025 | Dec 31, 2025 | $19.80M | – |
| Q3 FY2025 | Sep 30, 2025 | -$10.88M | – |
| Q2 FY2025 | Jun 30, 2025 | -$11.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.94M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.53M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.96M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.73M | – |
| Q4 FY2023 | Dec 31, 2023 | -$12.55M | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.05M | – |
| Q2 FY2023 | Jun 30, 2023 | -$17.49M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.56M | – |
| Q4 FY2022 | Dec 31, 2022 | -$22.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$23.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$24.57M | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.16M | – |
| Q4 FY2021 | Dec 31, 2021 | -$62.89M | – |
| Q3 FY2021 | Sep 30, 2021 | -$18.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$23.67M | -459.7% |
| Q1 FY2021 | Mar 31, 2021 | -$27.26M | – |
| Q4 FY2020 | Dec 31, 2020 | -$39.64M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.02M | – |
| Q2 FY2020 | Jun 30, 2020 | $6.58M | – |
| Q1 FY2020 | Mar 31, 2020 | -$27.69M | – |
| Q4 FY2019 | Dec 31, 2019 | -$28.68M | – |
| Q3 FY2019 | Sep 30, 2019 | -$25.99M | – |
| Q2 FY2019 | Jun 30, 2019 | -$19.70M | – |
| Q1 FY2019 | Mar 31, 2019 | -$28.34M | – |
| Q4 FY2018 | Dec 31, 2018 | -$26.32M | – |
| Q3 FY2018 | Sep 30, 2018 | -$22.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$27.17M | – |
| Q1 FY2018 | Mar 31, 2018 | -$16.67M | – |
| Q4 FY2017 | Dec 31, 2017 | -$12.28M | – |
| Q3 FY2017 | Sep 30, 2017 | -$12.45M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.57M | – |
| Q1 FY2017 | Mar 31, 2017 | -$13.93M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.87M | – |
| Q3 FY2016 | Sep 30, 2016 | -$11.68M | – |
See a number that looks wrong?